Skip to main content
Select Page

Enrolling Trials At Houston

SBA Dermatology

Dermatology

Upcoming: Masseter Muscle Prominence (square-shaped jawline)

Upcoming Enrollment! 

  • Ages 18+
  • BMI less than 30 kg/m2
  • Must not have a history of or current TMJD
  • Must not have history of dental or surgical procedures for lower facial shaping or masseter reduction
  • 15 visits over 12 months
  • Injection treatment
  • Qualified patients may receive compensation

*Other study eligibility criteria apply

SBA Dermatology

Hidradenitis Suppurativa

Must have tried ONE of the following medications in the past for the specific amount of time and did not have success:

  *For 12+ weeks: Infliximab-Remicade, Adalimumab-Humira, Etanercept-Enbrel

  OR

  *For 16+ weeks: Certolizumab-Cimzia, Secukinumab-Cosentyx, Ixekizumab-Taltz, Brodalumab-Siliq

  • Ages 12 and older
  • Up to 2.5 years duration
  • Oral extended-release tablet
  • Qualified patients may receive up to $1,820

      *Other study eligibility criteria apply


SBA Dermatology

Upcoming: Actinic Keratosis (body)

Must have AK’s on the main body area (e.g. back, shoulders, chest, arms, hands, legs)

  • Ages 18 and older
  • 6-8 visits over 1-1.5 years
  • Topical gel + red light photodynamic therapy (PDT) – 1 or 2 treatments total
  • Qualified patients may receive up to $760 – $1,070

*Other study eligibility criteria apply

Plaque Psoriasis

Plaque Psoriasis

Must be a male or a female not of childbearing potential

  • Ages 18 to 75
  • Moderate to severe amount of psoriasis
  • Plaques must be moderate to severe in severity
  • 13 visits over 7 months
  • Oral capsule treatment
  • Qualified patients may receive compensation

*Other study eligibility criteria apply

Plaque Psoriasis

Plaque Psoriasis

Must have Plaque Psoriasis covering 10%+ of body (excluding scalp)

  • Ages 18+
  • Moderate to severe amount of psoriasis
  • Plaques must be moderate to severe in severity
  • 23 visits over 156 weeks
  • Topical and Photoherapy treatment
  • Qualified patients may receive compensation

*Other study eligibility criteria apply

Common Wart

Upcoming: Common Wart

Must have at least 3 but not more than 20 warts!

  • Ages 12+
  • Must not have a history of keloid formation
  • 14 visits over 30 weeks
  • Injection treatment
  • Qualified patients may receive compensation

*Other study eligibility criteria apply

Vitiligo

Vitiligo (Non-Segmental)

Must have non-segment vitiligo on both the face and main body areas

  • Ages 18 and older
  • 11 visits over 1 year
  • Oral capsule treatment
  • Qualified patients may receive up to $836

*Other study eligibility criteria apply

Adolescent Common Warts

Adolescent Common Warts

Must have 1 – 8 common warts (usually found on the hands or fingers)

  • Ages 12-17
  • Up to 14 visits over 6 months 
  • Dissolvable skin patch
  • Qualified patients may receive up to $850

*Other study eligibility criteria apply

SBA Dermatology

Future Studies

Sign up for future clinical research studies!

Advancing medicine through clinical research. Past studies have included:

  • Acne
  • Actinic Keratosis
  • Alopecia Areata 
  • Atopic Dermatitis (eczema)
  • Cosmetic (cosmetic/anti-aging)
  • Hyperhidrosis (excessive underarm sweating)
  • Photodamage (sun damage)
  • Plaque Psoriasis
  • Rosacea
  • Seborrheic Dermatitis

Click Study Details to add your name to the waiting list for upcoming and future studies. We will alert you when we begin a new study.

To learn more about the following trials or other dermatology research being conducted at our Houston center, choose one of the links below or call our office at 713-850-0240.